A novel option for prandial insulin therapy: inhaled insulin.

about

Improved Postprandial Glucose with Inhaled Technosphere Insulin Compared with Insulin Aspart in Patients with Type 1 Diabetes on Multiple Daily Injections: The STAT Study

P2860

Q58694740-358BAE3D-2BEB-4714-B1FB-52756212EF3F

P2860

A novel option for prandial insulin therapy: inhaled insulin.

Item

http://www.wikidata.org/entity/Q38942445

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

A novel option for prandial insulin therapy: inhaled insulin.

@en

type

Item

label

A novel option for prandial insulin therapy: inhaled insulin.

@en

prefLabel

A novel option for prandial insulin therapy: inhaled insulin.

@en

P1476

A novel option for prandial insulin therapy: inhaled insulin

@en

P2093

Aakif Ahmad

http://www.w3.org/2001/XMLSchema#string

George Dailey

http://www.w3.org/2001/XMLSchema#string

Viral Shah

http://www.w3.org/2001/XMLSchema#string

P2860

Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes

10-year follow-up of intensive glucose control in type 2 diabetes

Do data in the literature indicate that glycaemic variability is a clinical problem? Glycaemic variability and vascular complications of diabetes.

Correlates of insulin injection omission

Addition of biphasic, prandial, or basal insulin to oral therapy in type 2 diabetes.

Postprandial blood glucose predicts cardiovascular events and all-cause mortality in type 2 diabetes in a 14-year follow-up: lessons from the San Luigi Gonzaga Diabetes Study

Insulin adherence behaviours and barriers in the multinational Global Attitudes of Patients and Physicians in Insulin Therapy study

Accelerating and improving the consistency of rapid-acting analog insulin absorption and action for both subcutaneous injection and continuous subcutaneous infusion using recombinant human hyaluronidase

Targeting postprandial hyperglycemia.

P304

839-847

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/00325481.2016.1229555

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

128

http://www.w3.org/2001/XMLSchema#string

P50

Sarit Polsky

P577

2016-09-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27580306

http://www.w3.org/2001/XMLSchema#string

A novel option for prandial insulin therapy: inhaled insulin.

about

P2860

P2860

A novel option for prandial insulin therapy: inhaled insulin.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698